Strength
500 mg/1
Manufacturer
AvPAKNDC
50268072215
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA209953On Market Since
9/20/2022
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 500 MG TABLET has been published 164 times since May 10, 2023, and over the history we have for it it has declined 23.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1629 per EA |
|---|---|
| All-time high | $0.2647 (Jan 10, 2024) |
| All-time low | $0.1624 (Feb 18, 2026) |
| 52-week high | $0.1976 |
| 52-week low | $0.1624 |
| Median price | $0.2071 |
| Average price | $0.2036 |
| Largest weekly change | +17.6% (Aug 21, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by AvPAK, is $0.1629 per EA (NDC 50268072215), effective Jun 24, 2026.
How has the price of RANOLAZINE ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 23.6%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?
Since May 10, 2023, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1624 (Feb 18, 2026) to a high of $0.2647 (Jan 10, 2024), with a median of $0.2071 per EA.
Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RANOLAZINE ER 500 MG TABLET, is $0.1624 per EA — about 0% below RANOLAZINE ER 500 MG TABLET.
Who manufactures RANOLAZINE ER 500 MG TABLET?
RANOLAZINE ER 500 MG TABLET (NDC 50268072215) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification